- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02999997
Evaluation of Ronnie Gardiner Method in Individuals With Parkinson's Disease (RGM/PD)
Randomized Controlled Trial to Evaluate the Rhythm and Music Based Rehabilitation Method the Ronnie Gardiner Method Regarding Dual-task in Individuals With Parkinson's Disease
Parkinson's disease (PD) is typically associated with cognitive and movement related functional disabilities. One commonly described cognitive complaint is the ability to do several things simultaneously, defined as dual or multiple tasking. The Ronnie Gardiner Method (RGM) is a rhythm and music based rehabilitation intervention that includes components that will train this ability specifically in addition to postural control, motor learning, movement ability and general cognitive function. The aim with the present randomized controlled single-blinded trial is to evaluate the RGM with main focus on dual-task performance, compared to a control group, in individuals with PD. The control group will continue with everyday activities, including ordinary exercise activities, with no additional activity. Both groups will be evaluated pre-, post-, and after 3 months post intervention. Following outcome measures will be analyzed:
- dual task performance (motor-motor, and motor-cognitive)
- level of physical activity, motor function and balance
- cognitive function including memory and spatial function
- health-related quality of life, fear of falling, and freezing of gait
- qualitative interviews from focus group discussions
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ostergotland
-
Linkoping, Ostergotland, Sweden, 58185
- Neurological clinic, Linkoeping Universityhospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Parkinson's disease, stage 1,5 to 4 on the Hoehn & Yahr scale, community dwelling, stable medication, being able to walk at least 10 meters, being able to transport to the intervention facility, being able to follow instructions in Swedish
Exclusion Criteria:
- parkinsonism of other origin, color blindness, severely impaired vision or hearing
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Ronnie Gardiner Method (RGM)
Exercising two times/week according to the RGM program in groups of 15 participants (2 groups).
|
RGM includes functional exercises consisting of cognitively challenging multi-task exercises.
The exercises are performed sitting down or standing up with weight shifting exercises.
The practitioner projects unique symbols shaped as red or blue hands and feet on the wall in specific 'choreoscores' of 2-8 bars.
Red symbolizes left side of the body, blue the right side.
Each symbol is accompanied with a certain movement and sound code.
To the sound of rhythmical music the participants follow the symbols beat by beat, performing the movements and pronouncing the word.
The exercises are progressed by increasing the tempo of the music, or by using more symbols.
The practitioner uses a shirt with the color red on one side, and blue on the other side, in order to facilitate for the participants.
Other Names:
|
No Intervention: Control group
Participants in the control group are instructed to live their ordinary life.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Timed Up and Go Cognitive (TUGcog) (motor-cognitive dual task)
Time Frame: Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Time in seconds to complete the following sequence: stand up from a chair, walk 3 meters, turn, walk back to the chair and sit down with the addition of counting backwards with 7 from 100, 90, 80, 70, 60, or 50.
Number of errors are noted.
Higher speed indicated better function.
|
Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Timed Up and Go manual (TUG manual) (motor-motor dual task)
Time Frame: Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Time in seconds to complete the following sequence: stand up from a chair, walk 3 meters, turn, walk back to the chair and sit down with the additional task to carry a tray with two glasses of water.
Higher speed indicates better function.
|
Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dual-task cost (DTC)
Time Frame: Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Measuring the difference between Timed Up and Go (TUG) single task and TUG cognitive and manual respectively
|
Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Mini-BESTest (Balance Evaluation Systems Test)
Time Frame: Change from Baseline through study completion (at 12 weeks) and at 3 months
|
A balance test focusing on dynamic balance and can be conducted in 10-15 minutes.
|
Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Four Step Square Test, FSST
Time Frame: Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Patient steps over four canes set-up like a cross on the floor with the tips of the canes facing together.
At the start of the test, the patient stands on the upper left square (in Square 1, facing Square 2).
The stepping sequence is (clockwise): Square 1, Square 2, Square 4, Square 3, return to Square 1 with the feet.
Then (counterclockwise): Back to Square 3, Square 4, Square 2, and end in Square 1 with both feet.
|
Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Berg Balance Scale
Time Frame: Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Static and dynamic activities of varying difficulty are performed.
Item-level scores range from 0-4, determined by ability to perform the assessed activity.
Item scores are summed.
Maximum score = 56
|
Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Chair stand 30 seconds
Time Frame: Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Standing up and sitting down, hands crossed over chest, as many times as possible for 30 seconds.
|
Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Montreal Cognitive Assessment (MoCA)
Time Frame: Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Screening of cognitive function.
License has been approved.
|
Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Auditory memory test, direct and delayed
Time Frame: Change from Baseline through study completion (at 12 weeks) and at 3 months
|
A text is read to the patient.
The patient is then required to reproduce the text as exactly as possible, and then again after appr. 10 minutes.
|
Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Symbol Digit Modalities Test (SDMT)
Time Frame: Change from Baseline through study completion (at 12 weeks) and at 3 months
|
A code key is presented to the patient where each code key represents a number between 1 and 9.
The patient is then required to solve as many codes as possible in 90 seconds.
|
Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Victoria Stroop test
Time Frame: Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Colored words are presented to the patient but in a different color than the word says, eg. the word BLUE appears in the color red and the patient is required to say "red", and not read the word "blue".
|
Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Grooved Pegboard
Time Frame: Change from Baseline through study completion (at 12 weeks) and at 3 months
|
The patient is required to move a number of metal sticks from one side to another as fast as possible.
A measure of fine motor control.
|
Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Trail Making Test A and B
Time Frame: Change from Baseline through study completion (at 12 weeks) and at 3 months
|
The patient is required to draw a line between the numbers 1 to 25 (A), and between the numbers 1 to 13 and vary to the letters A to L, i.e. 1-A-2-B-3-C, etc, without lifting the pen from the paper.
|
Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Rey complex figure
Time Frame: Change from Baseline through study completion (at 12 weeks) and at 3 months
|
The patient is required to copy a figure twice: the first time from a model in front of him/her; the second time without the model by memory only.
|
Change from Baseline through study completion (at 12 weeks) and at 3 months
|
WHODAS 2.0
Time Frame: Baseline
|
A questionnaire based on the International Classification of Functioning (ICF) for assessing impairments and function.
|
Baseline
|
Freezing of gait questionnaire
Time Frame: Change from Baseline through study completion (at 12 weeks) and at 3 months
|
A questionnaire with questions about freezing of gait
|
Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Parkinson's disease questionnaire 39 items (PDQ-39)
Time Frame: Change from Baseline through study completion (at 12 weeks) and at 3 months
|
A questionnaire for quality of life in people with Parkinson's disease.
License as been approved.
|
Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Falls Efficacy Scale International (FES-I)
Time Frame: Change from Baseline through study completion (at 12 weeks) and at 3 months
|
A questionnaire related to fear of falling.
|
Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Actigraphy with GeneActiv Armband
Time Frame: Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Actigraphy is a method to evaluate physical activity in a research person´s normal life.
GeneActiv is used to record number of steps daily but also time spent lying and standing which will give information about the activity.
|
Change from Baseline through study completion (at 12 weeks) and at 3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Petra Pohl, PhD, RPT, University Hospital, Linkoeping
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LUH-4865
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
ProgenaBiomeRecruitingParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
-
King's College LondonGlaxoSmithKlineCompletedParkinson Disease | Idiopathic Parkinson Disease | Parkinson Disease, PARK8United Kingdom
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
National Yang Ming UniversityUnknownEarly Onset Parkinson Disease | Early Stage Parkinson Disease
-
Michele Tagliati, MDRecruitingREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Mahatma Gandhi Institute of Medical SciencesCompletedStroke, Parkinson' s Disease, Neurological Impairments, Tele-rehabilitationIndia
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
University of DeustoCompletedPARKINSON DISEASE (Disorder)Spain
Clinical Trials on Ronnie Gardiner Method (RGM)
-
Universitair Ziekenhuis BrusselPsychiatric Clinic of Alexianen Zorggroep TienenRecruiting
-
Göteborg UniversityThe Sten A Olsson foundation for Research and CultureCompleted